957 related articles for article (PubMed ID: 11162134)
1. Efficient expression of the vascular endothelial growth factor gene in vitro and in vivo, using an adeno-associated virus vector.
Byun J; Heard JM; Huh JE; Park SJ; Jung EA; Jeong JO; Gwon HC; Kim DK
J Mol Cell Cardiol; 2001 Feb; 33(2):295-305. PubMed ID: 11162134
[TBL] [Abstract][Full Text] [Related]
2. Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart.
Su H; Lu R; Kan YW
Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13801-6. PubMed ID: 11095751
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic angiogenesis for ischemic syndromes.
Weisz A; Koren B; Fischer L; Lewis BS; Flugelman MY
Isr Med Assoc J; 2000 Jul; 2 Suppl():52-7. PubMed ID: 10909418
[TBL] [Abstract][Full Text] [Related]
4. Adeno-associated virus vectors simultaneously encoding VEGF and angiopoietin-1 enhances neovascularization in ischemic rabbit hind-limbs.
Chen F; Tan Z; Dong CY; Chen X; Guo SF
Acta Pharmacol Sin; 2007 Apr; 28(4):493-502. PubMed ID: 17376288
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo study of the expression vector encoding vascular endothelial growth factor.
Malecki M; Przybyszewska M; Janik P
Arch Immunol Ther Exp (Warsz); 2001; 49(3):243-6. PubMed ID: 11478399
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.
Middeke M; Hoffmann S; Hassan I; Wunderlich A; Hofbauer LC; Zielke A
Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):386-92. PubMed ID: 12518248
[TBL] [Abstract][Full Text] [Related]
7. The growth inhibition of hepatoma by gene transfer of antisense vascular endothelial growth factor.
Kang MA; Kim KY; Seol JY; Kim KC; Nam MJ
J Gene Med; 2000; 2(4):289-96. PubMed ID: 10953920
[TBL] [Abstract][Full Text] [Related]
8. rAAV-mediated long-term liver-generated expression of an angiogenesis inhibitor can restrict renal tumor growth in mice.
Davidoff AM; Nathwani AC; Spurbeck WW; Ng CY; Zhou J; Vanin EF
Cancer Res; 2002 Jun; 62(11):3077-83. PubMed ID: 12036917
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic angiogenesis using genetic transfection. An in vitro quantitative and functional study after gene code transfer for vascular endothelial growth factor].
Zaric V; Weltin D; Stephan D
Arch Mal Coeur Vaiss; 2000 Aug; 93(8):987-91. PubMed ID: 10989743
[TBL] [Abstract][Full Text] [Related]
10. Recombinant AAV vector encoding human VEGF165 enhances wound healing.
Deodato B; Arsic N; Zentilin L; Galeano M; Santoro D; Torre V; Altavilla D; Valdembri D; Bussolino F; Squadrito F; Giacca M
Gene Ther; 2002 Jun; 9(12):777-85. PubMed ID: 12040459
[TBL] [Abstract][Full Text] [Related]
11. Gene transfer of vascular endothelial growth factor and endothelial nitric oxide synthase--implications for gene therapy in cardiovascular diseases.
Dulak J; Józkowicz A; Guevara I; Dembińska-Kieć A
Pol J Pharmacol; 1999; 51(3):233-41. PubMed ID: 10600037
[TBL] [Abstract][Full Text] [Related]
12. Combination of VEGF(165)/Angiopoietin-1 gene and endothelial progenitor cells for therapeutic neovascularization.
Chen F; Tan Z; Dong CY; Li X; Xie Y; Wu Y; Chen X; Guo S
Eur J Pharmacol; 2007 Jul; 568(1-3):222-30. PubMed ID: 17553485
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence.
Saleh M; Stacker SA; Wilks AF
Cancer Res; 1996 Jan; 56(2):393-401. PubMed ID: 8542597
[TBL] [Abstract][Full Text] [Related]
14. Adeno-associated virus vectors for vascular gene delivery.
Lynch CM; Hara PS; Leonard JC; Williams JK; Dean RH; Geary RL
Circ Res; 1997 Apr; 80(4):497-505. PubMed ID: 9118480
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis.
Hajitou A; Sounni NE; Devy L; Grignet-Debrus C; Lewalle JM; Li H; Deroanne CF; Lu H; Colige A; Nusgens BV; Frankenne F; Maron A; Yeh P; Perricaudet M; Chang Y; Soria C; Calberg-Bacq CM; Foidart JM; Noël A
Cancer Res; 2001 Apr; 61(8):3450-7. PubMed ID: 11309307
[TBL] [Abstract][Full Text] [Related]
16. Angiogenesis by fibroblast growth factor 4 is mediated through an autocrine up-regulation of vascular endothelial growth factor expression.
Deroanne CF; Hajitou A; Calberg-Bacq CM; Nusgens BV; Lapière CM
Cancer Res; 1997 Dec; 57(24):5590-7. PubMed ID: 9407972
[TBL] [Abstract][Full Text] [Related]
17. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses.
Rissanen TT; Markkanen JE; Gruchala M; Heikura T; Puranen A; Kettunen MI; Kholová I; Kauppinen RA; Achen MG; Stacker SA; Alitalo K; Ylä-Herttuala S
Circ Res; 2003 May; 92(10):1098-106. PubMed ID: 12714562
[TBL] [Abstract][Full Text] [Related]
18. [The in vivo and in vitro effects on neovascularization of VEGF gene transfer with a new pseudotyped rAAV1 vector].
Yan H; Wu XB; Guo YH; Zhang P; Chen L; Dong XY; Wang GS; Gao W
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jan; 35(1):69-73. PubMed ID: 17386170
[TBL] [Abstract][Full Text] [Related]
19. Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes.
Saaristo A; Veikkola T; Enholm B; Hytönen M; Arola J; Pajusola K; Turunen P; Jeltsch M; Karkkainen MJ; Kerjaschki D; Bueler H; Ylä-Herttuala S; Alitalo K
FASEB J; 2002 Jul; 16(9):1041-9. PubMed ID: 12087065
[TBL] [Abstract][Full Text] [Related]
20. Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors.
Raake PW; Hinkel R; Müller S; Delker S; Kreuzpointner R; Kupatt C; Katus HA; Kleinschmidt JA; Boekstegers P; Müller OJ
Gene Ther; 2008 Jan; 15(1):12-7. PubMed ID: 17943147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
